Advertisements



Merck presents new data from comparative trials in Type 2 diabetes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2018

Merck (MRK) Presents New Data from Januvia Diabetes Studies

Merck (MRK) produces new data from two studies on type II diabetes medicine Januvia (sitagliptin), which supports the drug's clinical profile. Merck & Co., Inc MRK presented new data from two studies, evaluating its type II di.....»»

Category: dealsSource: nytJun 25th, 2018

Arcutis Biotherapeutics presents new data from DERMIS-1, DERMIS-2 phase 3 trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 6th, 2021

One in 4 people who died of COVID-19 in English hospitals had diabetes, NHS data finds

Getty The National Health Service found that type 1 and type 2 diabetes was a leading underlying condition in those who died of C.....»»

Category: topSource: businessinsiderMay 15th, 2020

A vaccine that could cure diabetes to be tested at MGH against coronavirus

A generic vaccine that's shown promise in reversing type 1 diabetes long-term in trials at Massachusetts General Hospital will soon have a new target: the COVID-19 coronavirus......»»

Category: topSource: bizjournalsApr 9th, 2020

Mirati presents data from sitravatinib in combination with nivolumab trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 10th, 2019

Tandem Diabetes presents "positive" data from pediatric users of t:slim X2

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 30th, 2019

Merck presents data from pivotal neoadjuvant/adjuvant Phase 3 KEYNOTE-522 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 29th, 2019

Aeglea BioTherapeutics presents 20-dose data from pegzilarginase trials at SSIEM

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 3rd, 2019

Celyad presents preliminary interim data from SHRINK, alloSHRINK trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 5th, 2019

Provention Bio May Offer New Hope For People With Type 1 Diabetes With Latest Clinical Data

Provention Bio May Offer New Hope For People With Type 1 Diabetes With Latest Clinical Data.....»»

Category: topSource: seekingalphaJun 19th, 2019

Assembly Biosciences presents interim data from two Phase 2a ABI-H0731 trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 14th, 2019

Almost a quarter of the world’s population will be obese by 2045

New research using WHO data says 1 in 8 people will have type 2 diabetes unless more countries take action......»»

Category: topSource: marketwatchMay 24th, 2018

Merck"s (MRK) Keytruda Lung Cancer Data in Focus at ASCO

Merck (MRK) presents data from several cancer studies of its .....»»

Category: dealsSource: nytJun 4th, 2018

Merck Presents Positive Melanoma Data on Keytruda at ASCO

Merck (MRK) presents encouraging data from two pivotal advanced melanoma studies on its PD-L1 inhibitor, Keytruda. Merck & Co., .....»»

Category: personnelSource: nytJun 5th, 2018

Merck presents early data for STING agonist in advanced solid tumors/lymphomas

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 21st, 2018

Autolus presents initial AUTO3 data from Phase 1/2 Trials in B cell Malignancies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 2nd, 2018

Insys Therapeutics presents comparative EpiPen study data at AAAAI

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 25th, 2019

Spruce Biosciences presents data from tildacerfont trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 24th, 2021

BeyondSpring presents Phase 1 data on plinabulin w/ checkpoint inhibitors

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 24th, 2021

Axcella Health presents AXA1665-002 clinical study data at DDW

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 24th, 2021